miR-1911-3p Regulates Malignant Biological Behaviors and Glycolytic Activity of Triple-Negative Breast Cancer via FBLN5
Breast Cancer: Targets and Therapy · 2026-07 · Volume 18 · 1-13
DOI: 10.2147/bctt.s615715 ↗Kurz gefasst
Fachartikel in der Zeitschrift Breast Cancer: Targets and Therapy, 2026-07. Verfasst von Linna Kong und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast and Thyroid Surgery, Zibo Central Hospital, Zibo, 255020, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Breast and Thyroid Surgery, Zibo Central Hospital, Zibo, 255020, People's Republic of China.
- Qilu Medical University, Zibo, 255300, People's Republic of China.
ORCID-Profile: Tiantian Sun
Zitieren
APA
Kong, L., Zhang, H., Sui, X., Peng, X., & Sun, T. (2026). miR-1911-3p Regulates Malignant Biological Behaviors and Glycolytic Activity of Triple-Negative Breast Cancer via FBLN5. Breast Cancer: Targets and Therapy, Volume 18, 1-13. https://doi.org/10.2147/bctt.s615715
Vancouver
Kong L, Zhang H, Sui X, Peng X, Sun T. miR-1911-3p Regulates Malignant Biological Behaviors and Glycolytic Activity of Triple-Negative Breast Cancer via FBLN5. Breast Cancer: Targets and Therapy. 2026;Volume 18:1-13. doi:10.2147/bctt.s615715
BibTeX
@article{Kong2026,
author = {Kong, Linna and Zhang, Huihui and Sui, Xufang and Peng, Xueping and Sun, Tiantian},
title = {miR-1911-3p Regulates Malignant Biological Behaviors and Glycolytic Activity of Triple-Negative Breast Cancer via FBLN5},
journal = {Breast Cancer: Targets and Therapy},
year = {2026},
volume = {Volume 18},
pages = {1--13},
doi = {10.2147/bctt.s615715}
}
EUVIMED